Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Interest & Investment Income (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Interest & Investment Income for 3 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 12.64% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Dec 2025, down 20.81% year-over-year, with the annual reading at $21.4 million for FY2025, 20.81% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $5.3 million at Nuvation Bio, down from $6.0 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $7.1 million in Q2 2024, with the low at $4.8 million in Q2 2025.
  • Average Interest & Investment Income over 3 years is $6.1 million, with a median of $6.1 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income surged 43.2% in 2024, then tumbled 33.09% in 2025.
  • Over 3 years, Interest & Investment Income stood at $7.0 million in 2023, then dropped by 13.68% to $6.1 million in 2024, then dropped by 12.64% to $5.3 million in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $5.3 million, $6.0 million, and $4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.